Figure 1
Figure 1. Effects of hydroxycarbamide therapy. Effects on D50 (A) and DRBCs (B) after 6 months of hydroxycarbamide therapy. Values for D50 and % RBDCs (± SD) for 33 patients with Hb SS disease are plotted at baseline and after 6 months of hydroxycarbamide therapy.

Effects of hydroxycarbamide therapy. Effects on D50 (A) and DRBCs (B) after 6 months of hydroxycarbamide therapy. Values for D50 and % RBDCs (± SD) for 33 patients with Hb SS disease are plotted at baseline and after 6 months of hydroxycarbamide therapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal